Freya Biosciences

Series-A
freyabiosciences.com Biotech & Healthcare Copenhagen, Denmark
Total Funding $38M
Latest Round Undisclosed Series-A
Last Announced Nov 19, 2024
Investors 9 Backers
Decision Makers 5 Available

About Freya Biosciences

Driving immune-mediated therapeutic innovation for women. Freya focuses on the underlying drivers of disease, not just symptoms.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Copenhagen, Denmark
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website freyabiosciences.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $38,000,000 · Series-A

    Backed by OMX Ventures

Investors & Backers

9
OMX Ventures
Lead
Angelini Ventures
Bill & Melinda Gates Foundation
CE Ventures (CEIIF)
Corundum Systems Biology
Export and Investment Fund
Indaco Venture Partners
Mike Jafar Family Office
Sofinnova Partners

Funding History

2 Rounds
Series-A equity · Nov 19, 2024
Series-A equity · Dec 12, 2023

Round backers: OMX Ventures

Founders & Leadership

2

Colleen Acosta

CEO, Co-Founder

Work email & phone locked Unlock →

Johan van Hylckama Vlieg

CSO, Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts